Egalet records $2.91 million operating loss for month ended Dec. 31

By Caroline Salls

Pittsburgh, Jan. 25 – Egalet Corp. reported a $2.91 million operating loss for December on $2.37 million in total revenue, according to its monthly operating report filed Friday with the U.S. Bankruptcy Court for the District of Delaware.

The net loss for the month was $3.45 million.

The company had $35.72 million in cash and cash equivalents as of Dec. 31.

Wayne, Pa.-based Egalet is a specialty pharmaceutical company focused on developing pain treatments. The company filed bankruptcy on Oct. 30 under Chapter 11 case number 18-12439.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.